Ren Hui, Guo Sheng, Zhang Yi-Ying, Li Quan, Wang Heng-Bin, Geng Wan-Li, Shang Er-Xin, Qian Da-Wei, Duan Jin-Ao
National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae, Nanjing University of Chinese Medicine Nanjing 210023, China.
Lei Yun Shang Pharmaceutical Group Co., Ltd. Suzhou 215003, China.
Zhongguo Zhong Yao Za Zhi. 2022 Jan;47(1):215-223. doi: 10.19540/j.cnki.cjcmm.20211109.201.
An ultra-high performance liquid chromatography-tandem mass spectrometry(UHPLC-MS/MS) method was established to investigate the pharmacokinetic behaviors of psoralenoside, isopsoralenoside, calycosin-7-glucoside, ononin, psoralen, isopsoralen, methylnissolin, and neobavaisoflavone in rat plasma after oral administration of Bufei Huoxue Capsules. After SD rats were administered with Bufei Huoxue Capsules suspension by gavage, blood samples were collected from the inner canthus at different time points. After protein precipitation, plasma samples were separated on ACQUITY UPLC BEH C_(18) column(2.1 mm×100 mm, 1.7 μm). The mobile phase consisted of acetonitrile(A) and water(B) containing 0.1% formic acid in gradient elution. The positive and negative ions were measured simultaneously in the multi-reaction monitoring(MRM) mode. The pharmacokinetic parameters were calculated and fitted by DAS 3.2.8. Psoralenoside, isopsoralenoside, calycosin-7-glucoside, ononin, psoralen, isopsoralen, methylnissolin, and neobavaisoflavone were detected in the rat plasma after drug administration, with AUC_(0-t) of(3 357±1 348),(3 555±1 696),(3.03±0.88),(2.21±0.33),(1 787±522),(2 295±539),(5.69±1.41) and(3.40±0.75) μg·L~(-1)·h, and T_(max) of(1.56±0.62),(1.40±0.70),(0.21±0.05),(0.25±0.12),(0.26±0.11),(0.34±0.29),(0.74±0.59), and 0.25 h. The method is proved specific and repeatable and is suitable for the determination of psoralenoside, isopsoralenoside, calycosin-7-glucoside, ononin, pso-ralen, isopsoralen, methylnissolin, and neobavaisoflavone in the rat plasma, which can be applied to pharmacokinetic study.
建立了一种超高效液相色谱-串联质谱(UHPLC-MS/MS)法,用于研究大鼠口服补肺活血胶囊后血浆中补骨脂苷、异补骨脂苷、毛蕊异黄酮葡萄糖苷、芒柄花苷、补骨脂素、异补骨脂素、甲基异土木香内酯和新补骨脂异黄酮的药代动力学行为。将补肺活血胶囊混悬液灌胃给予SD大鼠后,于不同时间点从内眦采集血样。经蛋白沉淀后,血浆样品在ACQUITY UPLC BEH C₁₈柱(2.1 mm×100 mm,1.7 μm)上进行分离。流动相由含0.1%甲酸的乙腈(A)和水(B)组成,进行梯度洗脱。在多反应监测(MRM)模式下同时测定正、负离子。药代动力学参数采用DAS 3.2.8计算并拟合。给药后大鼠血浆中检测到补骨脂苷、异补骨脂苷、毛蕊异黄酮葡萄糖苷、芒柄花苷、补骨脂素、异补骨脂素、甲基异土木香内酯和新补骨脂异黄酮,AUC₀₋ₜ分别为(3357±1348)、(3555±1696)、(3.03±0.88)、(2.21±0.33)、(1787±522)、(2295±539)、(5.69±1.41)和(3.40±0.75)μg·L⁻¹·h,Tₘₐₓ分别为(1.56±0.62)、(1.40±0.70)、(0.21±0.05)、(0.25±0.12)、(0.26±0.11)、(0.34±0.29)、(0.74±0.59)和0.25 h。该方法具有特异性和重复性,适用于大鼠血浆中补骨脂苷、异补骨脂苷、毛蕊异黄酮葡萄糖苷、芒柄花苷、补骨脂素、异补骨脂素、甲基异土木香内酯和新补骨脂异黄酮的测定,可应用于药代动力学研究。